New #HFBeat episode! 🎙️
HFmrEF affects up to 1 in 4 patients with HF, yet many clinicians still struggle with how to classify and manage it.
Hear Barry Borlaug, MD & Jane Wilcox, MD discuss the new HFSA Scientific Statement on #HFmrEF with @MHBeasleyMD and @priyaumapathi.
📖 hfsa.org/heart-failure-mildl…...
🎧 hfsa.org/heart-failure-beat-…...
Yale Heart Failure retweeted
Congratulations to Drs. Sara Tabtabai and Sarah Abou Alaiwi!
Two @YaleCardiology researchers have received Women As One 2026 Mentorship Awards to support their research: Sara Tabtabai, MD, assistant professor of medicine, and Sarah Abou Alaiwi, MD, a clinical fellow.
More on their research.
medicine.yale.edu/internal-m…
ICYMI the March episode of #HFBeat is out 🎙
In this lively debate on MRAs in HFpEF/HFmrEF, Stormi Gale, PharmD, BCCP, FHFSA shares why phenotyping may be one of the biggest challenges in heart failure trials - from missed amyloid diagnoses in older studies to refining who we enroll today.
If we aren’t studying the right patients, are we drawing the right conclusions?
Listen here: hfsa.org/heart-failure-beat-…
@MHBeasleyMD @priyaumapathi @beaverspharmd @megfrasernp @JurgaTomek
youtube.com/shorts/AOjh3yQMA…
How do we turn patient-generated data into actionable heart failure care without overwhelming clinicians?
This episode of The Heart Failure Beat explores integrated health technologies, patient adherence, digital equity, and why multidisciplinary teams are essential for success.
Listen here: hfsa.org/heart-failure-beat-…
@MHBeasleyMD @priyaumapathi @LauraPetersNP @megfrasernp
🎙 New Episode of #HFBeat
How should we be thinking about MRAs in HFpEF and HFmrEF today? In this lively debate, Stormi Gale, PharmD, BCCP, FHFSA and Robert L Page II, PharmD, MSPH, FHFSA examine:
- Evidence from TOPCAT and FINEARTS-HF
- Trial design and phenotyping challenges
- CKM overlap and cardiorenal considerations
- Hyperkalemia risk and combination strategies
- Cost and access realities
A balanced, evidence-driven discussion to help clinicians navigate real-world decisions.
Listen here: hfsa.org/heart-failure-beat-…
@MHBeasleyMD @priyaumapathi @beaverspharmd @megfrasernp @JurgaTomek
How can digital health technologies improve heart failure care in real-world practice?
The new HFSA Scientific Statement on Integrated Healthcare Technologies (IHTs) in the March issue of Journal of Cardiac Failure explores the evidence behind digital interventions and their impact on patient outcomes.
Want a deeper dive? Listen to our podcast episode discussing the statement and its implications for HF care.
Listen now 🎧 hfsa.org/heart-failure-beat-…
🎧 New episode of The Heart Failure Beat is out!
In this episode, Laura Peters, DNP explains why heart failure care shouldn’t rely on any one single device and how integrating wearables, implantable devices, telehealth, and AI can lead to more actionable, patient-centered care.
Bonus! The authors developed practical resources to help clinicians put this new guidance into practice hfsa.org/integrated-health-t…
Listen here: hfsa.org/heart-failure-beat-…
@MHBeasleyMD @priyaumapathi @LauraPetersNP @megfrasernp
New #HFBeat episode out now! Do we have evidence for inpatient sodium restriction in HF? In this preview, Dr. Tariq Ahmad explains why existing studies haven’t answered the question - and why a VA-commissioned expert review concluded sodium restriction for admitted HF patients isn’t supported.
Listen here: hfsa.org/heart-failure-beat-…
@MHBeasleyMD @priyaumapathi @YaleHFdoc
youtube.com/shorts/pliO7q7ft…
Yale Heart Failure retweeted
Our HCM Center is excited to welcome world expert Dr Rachel Lampert to @HarringtonHVI @UHhospitals as our 2025 HCM Visiting Professor this week discussing Exercise in HCM. @EiranGorodeski @shishem @JudyMackall
Yale Heart Failure retweeted
🚨Leadership Opportunity🚨
Yale Department of Anesthesiology is seeking an exceptional leader to join us as the Chief of Cardiothoracic Anesthesiology.
Click the link below to apply!
apply.interfolio.com/171094?…
Yale Heart Failure retweeted
Replying to @jfreeMD
@jfreeMD discusses managing atrial fibrillation in patients with heart failure during this presentation for the #AHFTC lecture series. @YaleHF @YaleCardiology
youtu.be/AG1N5MwXZGs?si=znNM…
Yale Heart Failure retweeted
Join @quin_denfeld to learn about frailty, tools available for assessment of frailty, and how frailty influences diagnosis, prognosis, and candidacy for advanced therapies in patients with heart failure. #AHFTC @YaleHF youtu.be/XmOXpv7qh1k?si=jNXL…
Yale Heart Failure retweeted
What is the recommended anticoagulation approach for #LVAD patients, and what is the reasoning behind it? Watch this talk from the #AHFTC lecture series to learn more. @YaleHF @YaleCardiology @YNHH
youtu.be/now5ckCV3AY?si=jvtf…
Yale Heart Failure retweeted
Check out Dr. Michael Sobieraj discussing risk scores to help determine the risk of right ventricular failure after LVAD implantation. #AHFTC @YaleHF @YaleCardiology
youtu.be/ai0DU8r2Fv8?si=iYOi…
Researchers at @YaleMed found that a specific group of patients who had AKI while in the hospital faced the higher risks of heart failure, kidney disease progression, and even death in the years after hospitalization. @YaleNephrology
m.yale.edu/c93j
Researchers at the Yale School of Medicine have discovered how specific genetic mutations can lead to left ventricular hypertrophy in Noonan syndrome, and have also identified a leukemia drug that shows promise as a therapeutic. @YaleMed
m.yale.edu/c9y9
Dr. Jeffrey Testani and colleagues have found that in heart failure, response to oral diuretics can be rapidly & accurately assessed using a urine sample collected 2 hr after oral diuretic dose, along with the Natriuretic Response Prediction Equation.
academic.oup.com/eurheartj/a…
Diagnosis and Management of Cardiogenic Shock by Dr. Lavanya Bellumkonda. In summary, "Early identification, risk stratification, and understanding the nuances of presentation may help with selecting appropriate treatment strategies." @YaleCardiology
journals.lww.com/co-critical…






















